A prophylactically implanted cardioverter defibrillator reduced all-cause mortality in myocardial infarction

Hlatky, Mark A.
November 2002
ACP Journal Club;Nov/Dec2002, Vol. 137 Issue 3, p81
Academic Journal
Discusses research being done on the efficacy of implanted cardioverter defibrillator and conventional therapy in reducing mortality in patients with myocardial infarction. Reference to study by A.J. Moss and colleagues, published in the 2002 issue of the 'New England Journal of Medicine'; Information on the study population; Administration of the treatment approaches.


Related Articles

  • Logit and Fuzzy Models in Data Analysis: Estimation of Risk in Cardiac Patients. P. Honzík; L. Krivan; P. Lokaj; R. Lábrová; Z. Nováková; B. Fišer; N. Honzíková // Physiological Research;2010 Supplement 1, Vol. 59, pS89 

    The aim of this study was a comparison of risk stratification for death in patients after myocardial infarction (MI) and of risk stratification for malignant arrhythmias in patients with implantable cardioverter-defibrillator (ICD). The individual risk factors and more complex approaches were...

  • Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both. Solomon, Scott D.; Zelenkofske, Steve; McMurray, John J.V.; Finn, Peter V.; Velazquez, Eric; Ertl, George; Harsanyi, Adam; Rouleau, Jean L.; Maggioni, Aldo; Kober, Lars; White, Harvey; Van de Werf, Frans; Pieper, Karen; Califf, Robert M.; Pfeffer, Marc A. // New England Journal of Medicine;6/23/2005, Vol. 352 Issue 25, p2581 

    Background: The risk of sudden death from cardiac causes is increased among survivors of acute myocardial infarction with reduced left ventricular systolic function. We assessed the risk and time course of sudden death in high-risk patients after myocardial infarction. Methods: We studied 14,609...

  • MINERVA.  // BMJ: British Medical Journal;7/18/2015, Vol. 351 Issue 8017, ph3724 

    The section offers health research as of July 18, 2015. More than 500,000 children die from diarrhoea yearly due to withholding of fluids and food by parents. A study of patient characteristics with Parkinson's disease in Canada have found three distinct subtypes. A California database showed...

  • Implantable devices improve survival rate.  // USA Today Magazine;Oct96, Vol. 125 Issue 2617, p4 

    Reports that implantable defribulators are effective in preventing sudden cardiac death in 95 percent of patients with arrhythmia. The use of electrical shock on improperly functioning parts of the heart; Details of how a defribulator works.

  • Defibrillators beat drugs. Hensley, Scott // Modern Healthcare;1/20/97, Vol. 27 Issue 3, p33 

    Reports on the findings of a study sponsored by Guidant Corporation, on implantable defibrillators. Methodology of the study; Comparison of patients with implanted defibrillators and those who had drug therapy; Description of the defibrillator; Cost of the respective treatments; Criticisms of...

  • Keeping pace with implanted defibrillators. Kruse, Lisa; Demarco, Mary Karen; Moyer, Pamela; Guenther, Leslie; Wagner, Amber; Torrelli, Virginia; Leone, Debbie // RN;Aug98, Vol. 61 Issue 8, p30 

    Focuses on the use of modern implantable cardioverter defibrillator (ICD) technology in the United States, highlighting the pre-and postop care and teaching that patients will require. Background information on ICD technology; What prompts the use of ICDs; Description of the care a patient with...

  • Smaller quadripolar cardiac resynchronization defibrillator.  // British Journal of Hospital Medicine (17508460);Oct2011, Vol. 72 Issue 10, p552 

    The article offers information on the use of Unify Quadra cardiac resynchronization therapy defibrillator with the Quartet left ventricular pacing lead; included are comments from consultant cardiologist Dr. Amir Zaidi from the Central Manchester University Hospitals NHS Foundation Trust.

  • ELECTROPHYSIOLOGY. Lindsay, Alistair; Qureshi, Katie // Heart;Dec2007, Vol. 93 Issue 12, p1649 

    An abstract on the efficiency of implantable cardioverter-defibrillator (ICD) devices in hypertrophic cardiomyopathy is presented.

  • Sex Differences in Implantable Cardioverter-Defibrillator Outcomes: Findings From a Prospective Defibrillator Database. MacFadden, Derek R.; Crystal, Eugene; Krahn, Andrew D.; Mangat, Iqwal; Healey, Jeffrey S.; Dorian, Paul; Birnie, David; Simpson, Christopher S.; Khaykin, Yaariv; Pinter, Arnold; Nanthakumar, Kumaraswamy; Calzavara, Andrew J.; Austin, Peter C.; Tu, Jack V.; Lee, Douglas S. // Annals of Internal Medicine;2/7/2012, Vol. 156 Issue 3, p195 

    Background: Sex differences in the use and outcomes of implantable cardioverter-defibrillators (ICDs) have not been fully studied. Objective: To examine potential sex differences in ICD implantation and device outcomes. Design: Health payer-mandated, prospective study of patients referred for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics